PipelinePharma Logo
PipelinePharma Logo

CTD Dossier Marketplace

Direct connection with CTD dossier (IP) owners and manufacturers

Marketing Authorizations Database

Search across marketing authorization registers
Sign in Get started

Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Ursodeoxycholic acid manufacturers

Filters

Filters

Filters , active

Country of origin : India
None products found

ursodeoxycholic acid

Tablets 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Comments
BE studies are not available
Manufacturer #21496

This CTD dossier owner and manufacturer is a fully integrated pharmaceutical corporation with a global reach. The company specializes in CMO and CDMO pharmaceutical preparations in a variety of dosage forms for a variety of therapeutic categories. GSK, Pfizer, Sanofi, Novartis, Mylan, Apotex, Adcock Ingram, and other MNCs manufacture formulations in various dosage forms for customers in 55 countries in important markets such as Europe, Australia & New Zealand, Canada, Japan, Far East Asia, GCC, Africa, LATAM, and CIS.

Manufacturer usually replies in 19 days

ursodeoxycholic acid

Tablets 150 mg, 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20224

The company is a pharmaceutical manufacturer engaged in the manufacturing of a wide range of pharmaceutical products including tablets, injections, syrups, suspensions and capsules, producing these pharmaceutical products in accordance with established industry norms and supplying them to clients through commercial channels to meet healthcare requirements.

Manufacturer usually replies in 36 days

ursodeoxycholic acid

Tablets 150 mg, 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19670

This pharmaceutical company is a leading manufacturer known for its commitment to research and development (R&D) and innovative products. They specialize in a wide range of therapeutic areas, including gastroenterology, cardiovascular health, diabetes, oncology, pain management, and nephrology. Their product portfolio encompasses various dosage forms such as finished formulations, DC granules and pellets, APIs, and intermediates. The company holds multiple GMP certifications (EU GMP, WHO GMP, ISO) and boasts a global presence in over 50 nations across the EU, North America, and other regions. They are dedicated to producing high-quality, affordable medications accessible to patients worldwide.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Ursodeoxycholic acid is a bile acid used to treat gallstones as well as to treat and prevent the progression of cystic fibrosis-related liver disorders. Suppliers of ursodeoxycholic acid market it in the form of 150mg, 250mg and 500mg oral tablets and capsules. The market for ursodeoxycholic acid is relatively competitive, populated with numerous manufacturing companies and suppliers. The largest manufacturers of ursodeoxycholic acid market globally are companies Mitsubishi Tanabe Pharma, Daewoong Chemical, and PharmaZell, Glenmark Pharmaceuticals, Dipharma Francis, Errengierre, and Grindeks. Ursodeoxycholic acid suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified ursodeoxycholic acid manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail prices per 50 (250mg) tablets of ursodeoxycholic acid fall into an approximate range of 12,00 EUR to 15,00 EUR, whereas the equivalent amount of 500mg tablets cost from 25,00 EUR to 30,00 EUR.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.